chr8-144356153-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012162.4(FBXL6):āc.1287G>Cā(p.Glu429Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,612,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012162.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBXL6 | NM_012162.4 | c.1287G>C | p.Glu429Asp | missense_variant | 8/9 | ENST00000331890.6 | |
FBXL6 | NM_024555.6 | c.1269G>C | p.Glu423Asp | missense_variant | 8/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBXL6 | ENST00000331890.6 | c.1287G>C | p.Glu429Asp | missense_variant | 8/9 | 1 | NM_012162.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250722Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135778
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460664Hom.: 0 Cov.: 35 AF XY: 0.00000275 AC XY: 2AN XY: 726640
GnomAD4 genome AF: 0.000118 AC: 18AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 14, 2023 | The c.1287G>C (p.E429D) alteration is located in exon 8 (coding exon 8) of the FBXL6 gene. This alteration results from a G to C substitution at nucleotide position 1287, causing the glutamic acid (E) at amino acid position 429 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at